After laying off a fourth of its staff, gene therapy startup SwanBio sees fresh financing as it heads towards the clinic

Just a few short weeks after SwanBio laid off a quarter of its 60-person workforce, it has returned with $56 million in new financing …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Af­ter lay­ing off a fourth of its staff, gene ther­a­py start­up Swan­Bio sees fresh fi­nanc­ing as it heads to­wards the clin­ic